Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1976 1
1982 1
1984 2
1986 1
1989 1
1990 1
1991 1
1993 3
1994 4
1995 4
1996 8
1997 4
1999 1
2000 2
2001 4
2002 5
2003 11
2004 7
2005 7
2006 13
2007 18
2008 39
2009 26
2010 9
2011 14
2012 13
2013 10
2014 3
2015 3
2016 5
2017 4
2018 3
2019 3
2020 2
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18217166

224 results

Results by year

Filters applied: . Clear all
Page 1
Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J, Cabaret O, Canonico M, Verstuyft C, Dubert L, Becquemont L, Guiochon-Mantel A, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Bouligand J, et al. Clin Pharmacol Ther. 2011 Jan;89(1):60-4. doi: 10.1038/clpt.2010.241. Epub 2010 Nov 24. Clin Pharmacol Ther. 2011. PMID: 21107315
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Canonico M, et al. J Thromb Haemost. 2006 Jun;4(6):1259-65. doi: 10.1111/j.1538-7836.2006.01933.x. J Thromb Haemost. 2006. PMID: 16706969 Free article.
Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
Bouaziz E, Canonico M, Verstuyft C, Carcaillon L, Martin F, Scarabin PY, Guiochon-Mantel A; EStrogen, THromboEmbolism Risk (ESTHER) Study Group. Bouaziz E, et al. Maturitas. 2009 Oct 20;64(2):136-8. doi: 10.1016/j.maturitas.2009.08.013. Epub 2009 Sep 25. Maturitas. 2009. PMID: 19782484 Free article.
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Canonico M, et al. Circulation. 2007 Feb 20;115(7):840-5. doi: 10.1161/CIRCULATIONAHA.106.642280. Circulation. 2007. PMID: 17309934 Clinical Trial.
224 results